Dr. Jonathan Power, an assistant professor of psychiatry at Weill Cornell Medicine, has been named a recipient of the second annual 1907 Trailblazer Award from the 1907 Foundation.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, called dry age-related macular degeneration (dry AMD), and used it to identify new treatment modalities and drug targets.
In the era of COVID-19 and evolving technology, emergency care providers need to recognize that their care must extend beyond the hospital walls, says Dr. Rahul Sharma, chair of emergency medicine at Weill Cornell Medicine and co-author of a new commentary in NEJM Catalyst.
While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.
Weill Cornell Medicine researchers have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes. The research will be conducted in mouse models of this disease.
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell’s Ithaca campus.
COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis.
A type of blood thinner may be more effective than aspirin at reducing the risk of recurrent stroke in a subset of stroke patients who experience problems with their hearts’ left ventricle, according to a new study led by Weill Cornell Medicine investigators.
Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium.
Omicron — the latest coronavirus variant to be labeled a “variant of concern” — has been spreading rapidly in the United States and dozens of countries around the world.
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.
For Dr. Jay Varma, the COVID-19 pandemic underscores the powerful, pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.
The National Human Genome Research Institute has funded a multi-institutional Center of Excellence in Genome Sciences (CEGS), based at Weill Cornell Medicine, to develop new tools to study the major product of the human genome, called ribonucleic acid (RNA), and determine how RNA functions to orchestrate the unique patterns of protein expression seen in human tissues and in disease.
Nursing homes acquired by private equity companies saw an increase in emergency room visits and hospitalizations among long-stay residents and an uptick in Medicare costs, according to a new study from Weill Cornell Medicine investigators.
Some of the latest research discoveries in neurodegenerative disease and their potential therapeutic applications were featured at the ninth annual Appel Alzheimer's Disease Research Institute Symposium, held remotely on Nov. 9.
About 28 million children became eligible for the COVID-19 vaccine after the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) approved and created guidelines for children ages 5 to 11 to receive the Pfizer/BioNTech COVID-19 vaccine. But as the vaccine rollout begins for younger kids, many parents may have questions.
